Cyclosporine Supplier-Buyer Network — Trade Flow Analysis

Name: Cyclosporine Supplier-Buyer Trade Network Dataset — 177+ Indian Exporters, 12+ Importers, 100+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Cyclosporine supplier network, Cyclosporine buyers, pharmaceutical export India, Cyclosporine trade data

TransData Nexus

Cyclosporine

India Pharmaceutical Trade Intelligence

$12.1M177 Suppliers100 CountriesHS 30049099

ExportsIndia → UNITED STATES26.8%India → TURKEY22.6%

ImportsFRANCE → India$28.8M UNITED STATES → India$2.0M

#1 Supplier: STRIDES PHARMA

Who Supplies Cyclosporine? Top Manufacturers & Buyers 2026 — STRIDES PHARMA SCIENCE LIMITED Leads | TransData Nexus | TransData Nexus

1STRIDES PHARMA SCIENCE LIMITED

STRIDES PHARMA SCIENCE LIMITED is the first-largest Cyclosporine exporter from India, with a market share of 21.8% and a total export value of $2.6M across 62 shipments. Their average shipment value of $42.7K is above the market average of $4.8K, suggesting premium or bulk contract pricing.

STRIDES PHARMA SCIENCE LIMITED serves 4 named buyers in our database. AVET PHARMACCEUTICALS INC. is the dominant customer, accounting for 55.9% of this supplier's tracked business. Top customers include:

• AVET PHARMACCEUTICALS INC. — $1.5M across 35 shipments (55.9% of this supplier's total exports)

• AVET PHARMACCEUTICALS INC. — $820.8K across 19 shipments (31.0% of this supplier's total exports)

• AVET PHARMACCEUTICALS INC. — $348.5K across 8 shipments (13.2% of this supplier's total exports)

• SENSUM SISTEMI Z RAC — $173 across 0 shipments (0.0% of this supplier's total exports)

Key Insight: STRIDES PHARMA SCIENCE LIMITED's per-shipment value of $42.7K is 791% above the market average of $4.8K, consistent with large-order contracts or value-added formulations.

2CONCORD BIOTECH LIMITED

CONCORD BIOTECH LIMITED is the second-largest Cyclosporine exporter from India, with a market share of 19.6% and a total export value of $2.4M across 14 shipments. Their average shipment value of $169.6K is above the market average of $4.8K, suggesting premium or bulk contract pricing.

CONCORD BIOTECH LIMITED serves 1 named buyer in our database. PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED — $2.4M across 14 shipments (100.0% of this supplier's total exports)

Key Insight: CONCORD BIOTECH LIMITED's per-shipment value of $169.6K is 3438% above the market average of $4.8K, consistent with large-order contracts or value-added formulations.

3PANACEA BIOTEC PHARMA LIMITED

PANACEA BIOTEC PHARMA LIMITED is the third-largest Cyclosporine exporter from India, with a market share of 12.1% and a total export value of $1.5M across 36 shipments. Their average shipment value of $40.9K is above the market average of $4.8K, suggesting premium or bulk contract pricing.

PANACEA BIOTEC PHARMA LIMITED serves 5 named buyers in our database. BANCO BOLIVARIANO C. is the dominant customer, accounting for 80.7% of this supplier's tracked business. Top customers include:

• BANCO BOLIVARIANO C. — $1.2M across 29 shipments (80.7% of this supplier's total exports)

• GENERICS & SPECIALIT — $148.8K across 4 shipments (10.1% of this supplier's total exports)

• RIGHT & BRIGHT INTER — $60.2K across 1 shipments (4.1% of this supplier's total exports)

• BANCO BOLIVARIANCO C — $42.1K across 1 shipments (2.9% of this supplier's total exports)

• PROSALUD FARMA S.A. — $32.5K across 1 shipments (2.2% of this supplier's total exports)

Key Insight: PANACEA BIOTEC PHARMA LIMITED's per-shipment value of $40.9K is 753% above the market average of $4.8K, consistent with large-order contracts or value-added formulations.

4STARCELL BIOTECH LLP

STARCELL BIOTECH LLP is the fourth-largest Cyclosporine exporter from India, with a market share of 4.8% and a total export value of $579.4K across 21 shipments. Their average shipment value of $27.6K is above the market average of $4.8K, suggesting premium or bulk contract pricing.

STARCELL BIOTECH LLP serves 3 named buyers in our database. M/S ARABIAN OASIS COMPANY is the dominant customer, accounting for 57.9% of this supplier's tracked business. Top customers include:

• M/S ARABIAN OASIS COMPANY — $335.6K across 12 shipments (57.9% of this supplier's total exports)

• ARABIAN OASIS COMPANY — $157.3K across 6 shipments (27.2% of this supplier's total exports)

• M/S ARABIAN OASIS COMPANY — $86.5K across 3 shipments (14.9% of this supplier's total exports)

Key Insight: STARCELL BIOTECH LLP's per-shipment value of $27.6K is 475% above the market average of $4.8K, consistent with large-order contracts or value-added formulations.

5GENETEC LIFESCIENCES

GENETEC LIFESCIENCES is the fifth-largest Cyclosporine exporter from India, with a market share of 3.3% and a total export value of $402.2K across 20 shipments. Their average shipment value of $20.1K is above the market average of $4.8K, suggesting premium or bulk contract pricing.

GENETEC LIFESCIENCES serves 1 named buyer in our database. APRAMEYA PHARMACHEM is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• APRAMEYA PHARMACHEM — $402.2K across 20 shipments (100.0% of this supplier's total exports)

Key Insight: GENETEC LIFESCIENCES's per-shipment value of $20.1K is 319% above the market average of $4.8K, consistent with large-order contracts or value-added formulations.

6MODERN DRUG HOUSE

MODERN DRUG HOUSE is the fifth-largest Cyclosporine exporter from India, with a market share of 2.9% and a total export value of $350.9K across 29 shipments. Their average shipment value of $12.1K is above the market average of $4.8K, suggesting premium or bulk contract pricing.

MODERN DRUG HOUSE serves 2 named buyers in our database. REPUBLIC OF YEMEN CLIENT CODE 02 is the dominant customer, accounting for 80.0% of this supplier's tracked business. Top customers include:

• REPUBLIC OF YEMEN CLIENT CODE 02 — $280.9K across 23 shipments (80.0% of this supplier's total exports)

• REPUBLIC OF YEMEN CLIENT CODE 02 — $70.1K across 6 shipments (20.0% of this supplier's total exports)

Key Insight: MODERN DRUG HOUSE's per-shipment value of $12.1K is 152% above the market average of $4.8K, consistent with large-order contracts or value-added formulations.

1United States

United States ranks as the first-largest destination for Cyclosporine imports from India, with a total trade value of $3.2M across 60 shipments — representing a 26.8% share of all Cyclosporine exports. The average shipment value of $54.1K is above the global average of $4.8K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Cyclosporine importers in United States: AVET PHARMACCEUTICALS INC., is the largest buyer, accounting for 54.9% ($1.8M) of this market's total imports.

• AVET PHARMACCEUTICALS INC., — $1.8M (54.9% of United States's total)

• AVET PHARMACCEUTICALS INC — $1.1M (34.3% of United States's total)

• AVET PHARMACCEUTICALS INC. — $348.5K (10.7% of United States's total)

Key Insight: United States's per-shipment average of $54.1K (1028% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Cyclosporine imports from India.

Primary Market

Secondary Market

2Turkey

Turkey ranks as the second-largest destination for Cyclosporine imports from India, with a total trade value of $2.7M across 14 shipments — representing a 22.6% share of all Cyclosporine exports. The average shipment value of $196.0K is above the global average of $4.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Cyclosporine importers in Turkey: PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED is the largest buyer, accounting for 86.6% ($2.4M) of this market's total imports.

• PAYAZ BIOMEDIKAL VE TIBBI CIHAZLARIC VE DIS TICARET LIMITED — $2.4M (86.6% of Turkey's total)

Key Insight: Turkey's per-shipment average of $196.0K (3987% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Turkey is a key market for Cyclosporine imports from India.

Primary Market

Secondary Market

3Ecuador

Ecuador ranks as the third-largest destination for Cyclosporine imports from India, with a total trade value of $1.3M across 0 shipments — representing a 10.4% share of all Cyclosporine exports. The average shipment value of $1.3M is above the global average of $4.8K, indicating high-value procurement contracts or branded formulations.

Key Insight: Ecuador's per-shipment average of $1.3M (26280% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Ecuador is a key market for Cyclosporine imports from India.

Primary Market

Secondary Market

4United Arab Emirates

United Arab Emirates ranks as the fourth-largest destination for Cyclosporine imports from India, with a total trade value of $992.0K across 0 shipments — representing a 8.2% share of all Cyclosporine exports. The average shipment value of $992.0K is above the global average of $4.8K, indicating high-value procurement contracts or branded formulations.

Key Insight: United Arab Emirates's per-shipment average of $992.0K (20589% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United Arab Emirates is a key market for Cyclosporine imports from India.

Primary Market

Secondary Market

5Saudi Arabia

Saudi Arabia ranks as the fifth-largest destination for Cyclosporine imports from India, with a total trade value of $581.3K across 18 shipments — representing a 4.8% share of all Cyclosporine exports. The average shipment value of $32.3K is above the global average of $4.8K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Cyclosporine importers in Saudi Arabia: M/S ARABIAN OASIS COMPANY is the largest buyer, accounting for 57.7% ($335.6K) of this market's total imports.

• M/S ARABIAN OASIS COMPANY — $335.6K (57.7% of Saudi Arabia's total)

• ARABIAN OASIS COMPANY — $157.3K (27.1% of Saudi Arabia's total)

Key Insight: Saudi Arabia's per-shipment average of $32.3K (574% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Saudi Arabia is a key market for Cyclosporine imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Cyclosporine.
2.Flow Mapping: 177 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,531 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 100 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2,531 Verified Shipments

177 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Cyclosporine

Cyclosporine

Who Supplies Cyclosporine? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Cyclosporine? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Cyclosporine Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1STRIDES PHARMA SCIENCE LIMITED

2CONCORD BIOTECH LIMITED

3PANACEA BIOTEC PHARMA LIMITED

4STARCELL BIOTECH LLP

5GENETEC LIFESCIENCES

6MODERN DRUG HOUSE

From Indian Factories to Global Pharmacies — How Cyclosporine Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Cyclosporine Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Turkey

3Ecuador

4United Arab Emirates

5Saudi Arabia

People Also Ask — Cyclosporine Supplier & Trade Network

Cyclosporine Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology